Weekly Digest – July 2024 Weekly Digest – July 2024 03 July 2024: Tisotumab Vedotin demonstrates superior survival outcomes in Advanced Cervical Cancer Tisotumab vedotin showed a 30% lower risk of death compared to chemotherapy in advanced cervical cancer Similar […]
Weekly Digest – July 2024 Weekly Digest – July 2024 01 July 2024: Eisai Announces independent development and commercialization of Farletuzumab Ecteribulin (FZEC) Antibody Drug Conjugate (ADC) Eisai and Bristol Myers Squibb are ending their $650 million collaboration on the […]
Weekly Digest – July 2024 Weekly Digest – July 2024 01 July 2024: Daiichi Sankyo secures $47M in ADC Patent arbitration against Seagen, faces upcoming conflict with Pfizer Daiichi Sankyo has emerged victorious in a longstanding patent arbitration dispute against […]
